”The need of the hour is twofold: first, continue the monetary policy support to the economy; and second, remain watchful of any durable inflationary pressures and sustained price momentum in key components so as to bring back the CPI inflation to 4 per cent over a period of time in a non-disruptive manner,” he said.
Category:
Pandemic
Latest
Marsh and Citi develop innovative cover, to help speed global delivery of COVAX vaccines
The policy is underwritten by six leading insurers: AXA XL, Chubb, Liberty Specialty Markets, Sovereign Risk Insurance, Swiss Re Corporate Solutions, and Tokio Marine HCC.
Stephen Kay, Political Risk Leader, Marsh said: “Striving for greater global vaccine equity by increasing vaccination rates worldwide will not only help countries recover faster from the impact of the pandemic, but may also reduce the risk of new variants that come from high levels of community transmission. This innovative structure will hasten that process by allowing Gavi to procure and distribute vaccines more speedily and with greater financial confidence.”
Indian businesses suffer more cyber attacks with remote working
Despite being over a year into remote working and the possibility of a likely shift to hybrid working models, security remains a key concern for the Indian businesses, the report said, adding that managing security risks is undoubtedly getting more challenging in the country.
For respondents from India, malware (56 per cent) is the leading source of security attacks followed by ransomware (53 per cent), and phishing and credential stuffing (both 43 per cent).
India to Brazil, Astra-Oxford vaccine is key to many nations’ Covid plan
he Astra vaccine costs a fraction of the price set by Pfizer and will be manufactured in multiple countries, from India to Brazil. It should be easier to deploy far and wide than other shots that need to be stored at ultra-cold temperatures. But if the U.K. partners can’t match the lofty efficacy levels Pfizer and Moderna delivered or roll out their inoculation quickly, the pandemic might continue spreading death and disease in countries relying on it.
Second Covid-19 wave can hit like tsunami:Maha CM
Addressing the state this evening, Thackeray reiterated that the best possible preventive measures are wearing a face mask, physical distancing, cleanliness and avoiding overcrowding in public places.
“We don’t have the vaccine yet, nor is there any treatment. So we have to stick to the preventive measures till then. Don’t be under any mistaken impression that because everything is being opened up, the coronavirus has been conquered,” he warned.
Sputnik V priced lower than Pfizer and Moderna vaccines: Sputnik V Twitter account
“Translating pharma lingo: the announced price of Pfizer of USD 19.50 and Moderna of USD 25-USD 37 per dose actually means their price of USD 39 and USD 50-USD 74 per person. Two doses are required per person for the Pfizer, Sputnik V and Moderna vaccines. The price of Sputnik V will be much lower,” the official account said.
WHO COVID envoy fears third wave, calls Europe response ‘incomplete’
He also said Europe had much to learn from Asian countries. “One has to react quickly to the virus, robustly and decisively,” he said. “Especially at the start, when the virus is still spreading very slowly in different communities. If you react half-heartedly, the problem will get bigger very quickly.”
India says local COVID-19 vaccine final trials could end within two months
“We are in the process of developing our indigenous vaccines, in the process of completing our third-phase trials in the next one or two months,” Harsh Vardhan told a web conference on the pandemic.
He reiterated the government’s plan was to immunise 200 million to 250 million Indians by July.
COVID-19 shots could reach first Americans by mid-December, top health official says
Some 70% of the U.S. population of 330 million would need to be inoculated to achieve “herd” immunity from the virus, a goal the country could achieve by May, according to Dr. Moncef Slaoui, chief scientific adviser for “Operation Warp Speed.”
G20 says it will strive for fair global access to COVID-19 vaccine
“The COVID-19 pandemic and its unprecedented impact in terms of lives lost, livelihoods and economies affected, is an unparalleled shock that has revealed vulnerabilities in our preparedness and response and underscored our common challenges,” the final communique said.
G20 nations will work to “protect lives, provide support with a special focus on the most vulnerable, and put our economies back on a path to restoring growth, and protecting and creating jobs for all”.
On vaccines, tests and treatments, the leaders said: “We will spare no effort to ensure their affordable and equitable access for all people.”
Pfizer Covid-19 vaccine could get UK approval this week, says report
Citing government sources, it said British regulators were about to start a formal appraisal of the vaccine, made by Pfizer Inc and BioNTech SE, and that the National Health Service had been told to be ready to administer it by Dec. 1.
The U.S. Food and Drug Administration said on Friday that it would meet on Dec. 10 to discuss whether to authorise the vaccine.
India’s COVID-19 tally rises to 90.95 lakh with 45,209 new cases
The total recoveries have surged to 85,21,617, pushing the national recovery rate to 93.69 per cent, while the COVID-19 case fatality rate has declined to 1.46 per cent.
There are 4,40,962 active cases in the country as on date which comprise 4.85 per cent of the total caseload, the data stated.
Moderna to charge govts $25-$37 for Covid-19 vaccine: CEO
“Our vaccine therefore costs about the same as a flu shot, which is between $10 and $50,” he was quoted as saying.